2018-2023 Global Benign Prostatic Hyperplasia Devices Consumption Market Report

August 2018 | 135 pages | ID: 22CCE419B7FEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Benign Prostatic Hyperplasia Devices market for 2018-2023.
Benign prostatic hyperplasia (BPH) is a urological disorder characterized by non-cancerous proliferation of prostate gland cells. This condition causes the gland to enlarge and, as a result, press against the urethra, constricting urine flow. This disorder is associated with aging, hormone imbalances, and abnormal cell growth.
The global benign prostatic hyperplasia market is expected to show considerable growth during the forecast period. This is attributed to rising geriatric population, increased awareness for prostate cancer and other urological disorders. However, the factors such as dearth of urologist in developing economies and lack of awareness regarding various urological diseases can hinder the growth of the market in the coming years. North America is account for the largest share of the benign prostatic hyperplasia market in 2016 due to high prevalence rate of benign prostatic hyperplasia. However, Asia is the fastest growing market due to the rise in various urological disorders and complications

Over the next five years, LPI(LP Information) projects that Benign Prostatic Hyperplasia Devices will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Benign Prostatic Hyperplasia Devices market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Transurethral Resection of the Prostate (TURP)
• Transurethral Microwave Therapy (TUMT)
• Transurethral Needle Ablation of the Prostate (TUNA)
• Laser Surgery
• Prostatic Stenting
• Others

Segmentation by application:

• Hospitals and Clinics
• Ambulatory Surgical Centers(ASC)
• Home
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Lumenis
• Olympus corporation
• Urologix
• Boston Scientific corporation
• Lisa Laser
• Medifocus
• Neotrac
• ProArc Medical LTD
• Urotech GMBH

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Benign Prostatic Hyperplasia Devices consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Benign Prostatic Hyperplasia Devices market by identifying its various subsegments.
• Focuses on the key global Benign Prostatic Hyperplasia Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Benign Prostatic Hyperplasia Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Benign Prostatic Hyperplasia Devices submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL BENIGN PROSTATIC HYPERPLASIA DEVICES CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Benign Prostatic Hyperplasia Devices Consumption 2013-2023
  2.1.2 Benign Prostatic Hyperplasia Devices Consumption CAGR by Region
2.2 Benign Prostatic Hyperplasia Devices Segment by Type
  2.2.1 Transurethral Resection of the Prostate (TURP)
  2.2.2 Transurethral Microwave Therapy (TUMT)
  2.2.3 Transurethral Needle Ablation of the Prostate (TUNA)
  2.2.4 Laser Surgery
  2.2.5 Prostatic Stenting
  2.2.6 Others
2.3 Benign Prostatic Hyperplasia Devices Consumption by Type
  2.3.1 Global Benign Prostatic Hyperplasia Devices Consumption Market Share by Type (2013-2018)
  2.3.2 Global Benign Prostatic Hyperplasia Devices Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Benign Prostatic Hyperplasia Devices Sale Price by Type (2013-2018)
2.4 Benign Prostatic Hyperplasia Devices Segment by Application
  2.4.1 Hospitals and Clinics
  2.4.2 Ambulatory Surgical Centers(ASC)
  2.4.3 Home
  2.4.4 Others
2.5 Benign Prostatic Hyperplasia Devices Consumption by Application
  2.5.1 Global Benign Prostatic Hyperplasia Devices Consumption Market Share by Application (2013-2018)
  2.5.2 Global Benign Prostatic Hyperplasia Devices Value and Market Share by Application (2013-2018)
  2.5.3 Global Benign Prostatic Hyperplasia Devices Sale Price by Application (2013-2018)

3 GLOBAL BENIGN PROSTATIC HYPERPLASIA DEVICES BY PLAYERS

3.1 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Players
  3.1.1 Global Benign Prostatic Hyperplasia Devices Sales by Players (2016-2018)
  3.1.2 Global Benign Prostatic Hyperplasia Devices Sales Market Share by Players (2016-2018)
3.2 Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Players
  3.2.1 Global Benign Prostatic Hyperplasia Devices Revenue by Players (2016-2018)
  3.2.2 Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Players (2016-2018)
3.3 Global Benign Prostatic Hyperplasia Devices Sale Price by Players
3.4 Global Benign Prostatic Hyperplasia Devices Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Benign Prostatic Hyperplasia Devices Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Benign Prostatic Hyperplasia Devices Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 BENIGN PROSTATIC HYPERPLASIA DEVICES BY REGIONS

4.1 Benign Prostatic Hyperplasia Devices by Regions
  4.1.1 Global Benign Prostatic Hyperplasia Devices Consumption by Regions
  4.1.2 Global Benign Prostatic Hyperplasia Devices Value by Regions
4.2 Americas Benign Prostatic Hyperplasia Devices Consumption Growth
4.3 APAC Benign Prostatic Hyperplasia Devices Consumption Growth
4.4 Europe Benign Prostatic Hyperplasia Devices Consumption Growth
4.5 Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption Growth

5 AMERICAS

5.1 Americas Benign Prostatic Hyperplasia Devices Consumption by Countries
  5.1.1 Americas Benign Prostatic Hyperplasia Devices Consumption by Countries (2013-2018)
  5.1.2 Americas Benign Prostatic Hyperplasia Devices Value by Countries (2013-2018)
5.2 Americas Benign Prostatic Hyperplasia Devices Consumption by Type
5.3 Americas Benign Prostatic Hyperplasia Devices Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Benign Prostatic Hyperplasia Devices Consumption by Countries
  6.1.1 APAC Benign Prostatic Hyperplasia Devices Consumption by Countries (2013-2018)
  6.1.2 APAC Benign Prostatic Hyperplasia Devices Value by Countries (2013-2018)
6.2 APAC Benign Prostatic Hyperplasia Devices Consumption by Type
6.3 APAC Benign Prostatic Hyperplasia Devices Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Benign Prostatic Hyperplasia Devices by Countries
  7.1.1 Europe Benign Prostatic Hyperplasia Devices Consumption by Countries (2013-2018)
  7.1.2 Europe Benign Prostatic Hyperplasia Devices Value by Countries (2013-2018)
7.2 Europe Benign Prostatic Hyperplasia Devices Consumption by Type
7.3 Europe Benign Prostatic Hyperplasia Devices Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Benign Prostatic Hyperplasia Devices by Countries
  8.1.1 Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Benign Prostatic Hyperplasia Devices Value by Countries (2013-2018)
8.2 Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption by Type
8.3 Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Benign Prostatic Hyperplasia Devices Distributors
10.3 Benign Prostatic Hyperplasia Devices Customer

11 GLOBAL BENIGN PROSTATIC HYPERPLASIA DEVICES MARKET FORECAST

11.1 Global Benign Prostatic Hyperplasia Devices Consumption Forecast (2018-2023)
11.2 Global Benign Prostatic Hyperplasia Devices Forecast by Regions
  11.2.1 Global Benign Prostatic Hyperplasia Devices Forecast by Regions (2018-2023)
  11.2.2 Global Benign Prostatic Hyperplasia Devices Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Benign Prostatic Hyperplasia Devices Forecast by Type
11.8 Global Benign Prostatic Hyperplasia Devices Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Lumenis
  12.1.1 Company Details
  12.1.2 Benign Prostatic Hyperplasia Devices Product Offered
  12.1.3 Lumenis Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Lumenis News
12.2 Olympus corporation
  12.2.1 Company Details
  12.2.2 Benign Prostatic Hyperplasia Devices Product Offered
  12.2.3 Olympus corporation Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Olympus corporation News
12.3 Urologix
  12.3.1 Company Details
  12.3.2 Benign Prostatic Hyperplasia Devices Product Offered
  12.3.3 Urologix Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Urologix News
12.4 Boston Scientific corporation
  12.4.1 Company Details
  12.4.2 Benign Prostatic Hyperplasia Devices Product Offered
  12.4.3 Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Boston Scientific corporation News
12.5 Lisa Laser
  12.5.1 Company Details
  12.5.2 Benign Prostatic Hyperplasia Devices Product Offered
  12.5.3 Lisa Laser Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Lisa Laser News
12.6 Medifocus
  12.6.1 Company Details
  12.6.2 Benign Prostatic Hyperplasia Devices Product Offered
  12.6.3 Medifocus Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Medifocus News
12.7 Neotrac
  12.7.1 Company Details
  12.7.2 Benign Prostatic Hyperplasia Devices Product Offered
  12.7.3 Neotrac Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Neotrac News
12.8 ProArc Medical LTD
  12.8.1 Company Details
  12.8.2 Benign Prostatic Hyperplasia Devices Product Offered
  12.8.3 ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 ProArc Medical LTD News
12.9 Urotech GMBH
  12.9.1 Company Details
  12.9.2 Benign Prostatic Hyperplasia Devices Product Offered
  12.9.3 Urotech GMBH Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Urotech GMBH News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Benign Prostatic Hyperplasia Devices
Table Product Specifications of Benign Prostatic Hyperplasia Devices
Figure Benign Prostatic Hyperplasia Devices Report Years Considered
Figure Market Research Methodology
Figure Global Benign Prostatic Hyperplasia Devices Consumption Growth Rate 2013-2023 (K Units)
Figure Global Benign Prostatic Hyperplasia Devices Value Growth Rate 2013-2023 ($ Millions)
Table Benign Prostatic Hyperplasia Devices Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Transurethral Resection of the Prostate (TURP)
Table Major Players of Transurethral Resection of the Prostate (TURP)
Figure Product Picture of Transurethral Microwave Therapy (TUMT)
Table Major Players of Transurethral Microwave Therapy (TUMT)
Figure Product Picture of Transurethral Needle Ablation of the Prostate (TUNA)
Table Major Players of Transurethral Needle Ablation of the Prostate (TUNA)
Figure Product Picture of Laser Surgery
Table Major Players of Laser Surgery
Figure Product Picture of Prostatic Stenting
Table Major Players of Prostatic Stenting
Figure Product Picture of Others
Table Major Players of Others
Table Global Consumption Sales by Type (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Consumption Market Share by Type (2013-2018)
Figure Global Benign Prostatic Hyperplasia Devices Consumption Market Share by Type (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Revenue by Type (2013-2018) ($ million)
Table Global Benign Prostatic Hyperplasia Devices Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Benign Prostatic Hyperplasia Devices Value Market Share by Type (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Sale Price by Type (2013-2018)
Figure Benign Prostatic Hyperplasia Devices Consumed in Hospitals and Clinics
Figure Global Benign Prostatic Hyperplasia Devices Market: Hospitals and Clinics (2013-2018) (K Units)
Figure Global Benign Prostatic Hyperplasia Devices Market: Hospitals and Clinics (2013-2018) ($ Millions)
Figure Global Hospitals and Clinics YoY Growth ($ Millions)
Figure Benign Prostatic Hyperplasia Devices Consumed in Ambulatory Surgical Centers(ASC)
Figure Global Benign Prostatic Hyperplasia Devices Market: Ambulatory Surgical Centers(ASC) (2013-2018) (K Units)
Figure Global Benign Prostatic Hyperplasia Devices Market: Ambulatory Surgical Centers(ASC) (2013-2018) ($ Millions)
Figure Global Ambulatory Surgical Centers(ASC) YoY Growth ($ Millions)
Figure Benign Prostatic Hyperplasia Devices Consumed in Home
Figure Global Benign Prostatic Hyperplasia Devices Market: Home (2013-2018) (K Units)
Figure Global Benign Prostatic Hyperplasia Devices Market: Home (2013-2018) ($ Millions)
Figure Global Home YoY Growth ($ Millions)
Figure Benign Prostatic Hyperplasia Devices Consumed in Others
Figure Global Benign Prostatic Hyperplasia Devices Market: Others (2013-2018) (K Units)
Figure Global Benign Prostatic Hyperplasia Devices Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Consumption Market Share by Application (2013-2018)
Figure Global Benign Prostatic Hyperplasia Devices Consumption Market Share by Application (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Value by Application (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Value Market Share by Application (2013-2018)
Figure Global Benign Prostatic Hyperplasia Devices Value Market Share by Application (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Sale Price by Application (2013-2018)
Table Global Benign Prostatic Hyperplasia Devices Sales by Players (2016-2018) (K Units)
Table Global Benign Prostatic Hyperplasia Devices Sales Market Share by Players (2016-2018)
Figure Global Benign Prostatic Hyperplasia Devices Sales Market Share by Players in 2016
Figure Global Benign Prostatic Hyperplasia Devices Sales Market Share by Players in 2017
Table Global Benign Prostatic Hyperplasia Devices Revenue by Players (2016-2018) ($ Millions)
Table Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Players (2016-2018)
Figure Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Players in 2016
Figure Global Benign Prostatic Hyperplasia Devices Revenue Market Share by Players in 2017
Table Global Benign Prostatic Hyperplasia Devices Sale Price by Players (2016-2018)
Figure Global Benign Prostatic Hyperplasia Devices Sale Price by Players in 2017
Table Global Benign Prostatic Hyperplasia Devices Manufacturing Base Distribution and Sales Area by Players
Table Players Benign Prostatic Hyperplasia Devices Products Offered
Table Benign Prostatic Hyperplasia Devices Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Benign Prostatic Hyperplasia Devices Consumption by Regions 2013-2018 (K Units)
Table Global Benign Prostatic Hyperplasia Devices Consumption Market Share by Regions 2013-2018
Figure Global Benign Prostatic Hyperplasia Devices Consumption Market Share by Regions 2013-2018
Table Global Benign Prostatic Hyperplasia Devices Value by Regions 2013-2018 ($ Millions)
Table Global Benign Prostatic Hyperplasia Devices Value Market Share by Regions 2013-2018
Figure Global Benign Prostatic Hyperplasia Devices Value Market Share by Regions 2013-2018
Figure Americas Benign Prostatic Hyperplasia Devices Consumption 2013-2018 (K Units)
Figure Americas Benign Prostatic Hyperplasia Devices Value 2013-2018 ($ Millions)
Figure APAC Benign Prostatic Hyperplasia Devices Consumption 2013-2018 (K Units)
Figure APAC Benign Prostatic Hyperplasia Devices Value 2013-2018 ($ Millions)
Figure Europe Benign Prostatic Hyperplasia Devices Consumption 2013-2018 (K Units)
Figure Europe Benign Prostatic Hyperplasia Devices Value 2013-2018 ($ Millions)
Figure Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption 2013-2018 (K Units)
Figure Middle East & Africa Benign Prostatic Hyperplasia Devices Value 2013-2018 ($ Millions)
Table Americas Benign Prostatic Hyperplasia Devices Consumption by Countries (2013-2018) (K Units)
Table Americas Benign Prostatic Hyperplasia Devices Consumption Market Share by Countries (2013-2018)
Figure Americas Benign Prostatic Hyperplasia Devices Consumption Market Share by Countries in 2017
Table Americas Benign Prostatic Hyperplasia Devices Value by Countries (2013-2018) ($ Millions)
Table Americas Benign Prostatic Hyperplasia Devices Value Market Share by Countries (2013-2018)
Figure Americas Benign Prostatic Hyperplasia Devices Value Market Share by Countries in 2017
Table Americas Benign Prostatic Hyperplasia Devices Consumption by Type (2013-2018) (K Units)
Table Americas Benign Prostatic Hyperplasia Devices Consumption Market Share by Type (2013-2018)
Figure Americas Benign Prostatic Hyperplasia Devices Consumption Market Share by Type in 2017
Table Americas Benign Prostatic Hyperplasia Devices Consumption by Application (2013-2018) (K Units)
Table Americas Benign Prostatic Hyperplasia Devices Consumption Market Share by Application (2013-2018)
Figure Americas Benign Prostatic Hyperplasia Devices Consumption Market Share by Application in 2017
Figure United States Benign Prostatic Hyperplasia Devices Consumption Growth 2013-2018 (K Units)
Figure United States Benign Prostatic Hyperplasia Devices Value Growth 2013-2018 ($ Millions)
Figure Canada Benign Prostatic Hyperplasia Devices Consumption Growth 2013-2018 (K Units)
Figure Canada Benign Prostatic Hyperplasia Devices Value Growth 2013-2018 ($ Millions)
Figure Mexico Benign Prostatic Hyperplasia Devices Consumption Growth 2013-2018 (K Units)
Figure Mexico Benign Prostatic Hyperplasia Devices Value Growth 2013-2018 ($ Millions)
Table APAC Benign Prostatic Hyperplasia Devices Consumption by Countries (2013-2018) (K Units)
Table APAC Benign Prostatic Hyperplasia Devices Consumption Market Share by Countries (2013-2018)
Figure APAC Benign Prostatic Hyperplasia Devices Consumption Market Share by Countries in 2017
Table APAC Benign Prostatic Hyperplasia Devices Value by Countries (2013-2018) ($ Millions)
Table APAC Benign Prostatic Hyperplasia Devices Value Market Share by Countries (2013-2018)
Figure APAC Benign Prostatic Hyperplasia Devices Value Market Share by Countries in 2017
Table APAC Benign Prostatic Hyperplasia Devices Consumption by Type (2013-2018) (K Units)
Table APAC Benign Prostatic Hyperplasia Devices Consumption Market Share by Type (2013-2018)
Figure APAC Benign Prostatic Hyperplasia Devices Consumption Market Share by Type in 2017
Table APAC Benign Prostatic Hyperplasia Devices Consumption by Application (2013-2018) (K Units)
Table APAC Benign Prostatic Hyperplasia Devices Consumption Market Share by Application (2013-2018)
Figure APAC Benign Prostatic Hyperplasia Devices Consumption Market Share by Application in 2017
Figure China Benign Prostatic Hyperplasia Devices Consumption Growth 2013-2018 (K Units)
Figure China Benign Prostatic Hyperplasia Devices Value Growth 2013-2018 ($ Millions)
Figure Japan Benign Prostatic Hyperplasia Devices Consumption Growth 2013-2018 (K Units)
Figure Japan Benign Prostatic Hyperplasia Devices Value Growth 2013-2018 ($ Millions)
Figure Korea Benign Prostatic Hyperplasia Devices Consumption Growth 2013-2018 (K Units)
Figure Korea Benign Prostatic Hyperplasia Devices Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Benign Prostatic Hyperplasia Devices Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Benign Prostatic Hyperplasia Devices Value Growth 2013-2018 ($ Millions)
Figure India Benign Prostatic Hyperplasia Devices Consumption Growth 2013-2018 (K Units)
Figure India Benign Prostatic Hyperplasia Devices Value Growth 2013-2018 ($ Millions)
Figure Australia Benign Prostatic Hyperplasia Devices Consumption Growth 2013-2018 (K Units)
Figure Australia Benign Prostatic Hyperplasia Devices Value Growth 2013-2018 ($ Millions)
Table Europe Benign Prostatic Hyperplasia Devices Consumption by Countries (2013-2018) (K Units)
Table Europe Benign Prostatic Hyperplasia Devices Consumption Market Share by Countries (2013-2018)
Figure Europe Benign Prostatic Hyperplasia Devices Consumption Market Share by Countries in 2017
Table Europe Benign Prostatic Hyperplasia Devices Value by Countries (2013-2018) ($ Millions)
Table Europe Benign Prostatic Hyperplasia Devices Value Market Share by Countries (2013-2018)
Figure Europe Benign Prostatic Hyperplasia Devices Value Market Share by Countries in 2017
Table Europe Benign Prostatic Hyperplasia Devices Consumption by Type (2013-2018) (K Units)
Table Europe Benign Prostatic Hyperplasia Devices Consumption Market Share by Type (2013-2018)
Figure Europe Benign Prostatic Hyperplasia Devices Consumption Market Share by Type in 2017
Table Europe Benign Prostatic Hyperplasia Devices Consumption by Application (2013-2018) (K Units)
Table Europe Benign Prostatic Hyperplasia Devices Consumption Market Share by Application (2013-2018)
Figure Europe Benign Prostatic Hyperplasia Devices Consumption Market Share by Application in 2017
Figure Germany Benign Prostatic Hyperplasia Devices Consumption Growth 2013-2018 (K Units)
Figure Germany Benign Prostatic Hyperplasia Devices Value Growth 2013-2018 ($ Millions)
Figure France Benign Prostatic Hyperplasia Devices Consumption Growth 2013-2018 (K Units)
Figure France Benign Prostatic Hyperplasia Devices Value Growth 2013-2018 ($ Millions)
Figure UK Benign Prostatic Hyperplasia Devices Consumption Growth 2013-2018 (K Units)
Figure UK Benign Prostatic Hyperplasia Devices Value Growth 2013-2018 ($ Millions)
Figure Italy Benign Prostatic Hyperplasia Devices Consumption Growth 2013-2018 (K Units)
Figure Italy Benign Prostatic Hyperplasia Devices Value Growth 2013-2018 ($ Millions)
Figure Russia Benign Prostatic Hyperplasia Devices Consumption Growth 2013-2018 (K Units)
Figure Russia Benign Prostatic Hyperplasia Devices Value Growth 2013-2018 ($ Millions)
Figure Spain Benign Prostatic Hyperplasia Devices Consumption Growth 2013-2018 (K Units)
Figure Spain Benign Prostatic Hyperplasia Devices Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption Market Share by Countries in 2017
Table Middle East & Africa Benign Prostatic Hyperplasia Devices Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Benign Prostatic Hyperplasia Devices Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Benign Prostatic Hyperplasia Devices Value Market Share by Countries in 2017
Table Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption Market Share by Type in 2017
Table Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption Market Share by Application in 2017
Figure Egypt Benign Prostatic Hyperplasia Devices Consumption Growth 2013-2018 (K Units)
Figure Egypt Benign Prostatic Hyperplasia Devices Value Growth 2013-2018 ($ Millions)
Figure South Africa Benign Prostatic Hyperplasia Devices Consumption Growth 2013-2018 (K Units)
Figure South Africa Benign Prostatic Hyperplasia Devices Value Growth 2013-2018 ($ Millions)
Figure Israel Benign Prostatic Hyperplasia Devices Consumption Growth 2013-2018 (K Units)
Figure Israel Benign Prostatic Hyperplasia Devices Value Growth 2013-2018 ($ Millions)
Figure Turkey Benign Prostatic Hyperplasia Devices Consumption Growth 2013-2018 (K Units)
Figure Turkey Benign Prostatic Hyperplasia Devices Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Benign Prostatic Hyperplasia Devices Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Benign Prostatic Hyperplasia Devices Value Growth 2013-2018 ($ Millions)
Table Benign Prostatic Hyperplasia Devices Distributors List
Table Benign Prostatic Hyperplasia Devices Customer List
Figure Global Benign Prostatic Hyperplasia Devices Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Benign Prostatic Hyperplasia Devices Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Benign Prostatic Hyperplasia Devices Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Benign Prostatic Hyperplasia Devices Consumption Market Forecast by Regions
Table Global Benign Prostatic Hyperplasia Devices Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Benign Prostatic Hyperplasia Devices Value Market Share Forecast by Regions
Figure Americas Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure Americas Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Figure APAC Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure APAC Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Figure Europe Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure Europe Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Figure Middle East & Africa Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure Middle East & Africa Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Figure United States Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure United States Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Figure Canada Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure Canada Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Figure Mexico Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure Mexico Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Figure Brazil Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure Brazil Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Figure China Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure China Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Figure Japan Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure Japan Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Figure Korea Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure Korea Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Figure Southeast Asia Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure Southeast Asia Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Figure India Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure India Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Figure Australia Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure Australia Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Figure Germany Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure Germany Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Figure France Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure France Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Figure UK Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure UK Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Figure Italy Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure Italy Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Figure Russia Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure Russia Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Figure Spain Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure Spain Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Figure Egypt Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure Egypt Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Figure South Africa Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure South Africa Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Figure Israel Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure Israel Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Figure Turkey Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure Turkey Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Figure GCC Countries Benign Prostatic Hyperplasia Devices Consumption 2018-2023 (K Units)
Figure GCC Countries Benign Prostatic Hyperplasia Devices Value 2018-2023 ($ Millions)
Table Global Benign Prostatic Hyperplasia Devices Consumption Forecast by Type (2018-2023) (K Units)
Table Global Benign Prostatic Hyperplasia Devices Consumption Market Share Forecast by Type (2018-2023)
Table Global Benign Prostatic Hyperplasia Devices Value Forecast by Type (2018-2023) ($ Millions)
Table Global Benign Prostatic Hyperplasia Devices Value Market Share Forecast by Type (2018-2023)
Table Global Benign Prostatic Hyperplasia Devices Consumption Forecast by Application (2018-2023) (K Units)
Table Global Benign Prostatic Hyperplasia Devices Consumption Market Share Forecast by Application (2018-2023)
Table Global Benign Prostatic Hyperplasia Devices Value Forecast by Application (2018-2023) ($ Millions)
Table Global Benign Prostatic Hyperplasia Devices Value Market Share Forecast by Application (2018-2023)
Table Lumenis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lumenis Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Lumenis Benign Prostatic Hyperplasia Devices Market Share (2016-2018)
Table Olympus corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Olympus corporation Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Olympus corporation Benign Prostatic Hyperplasia Devices Market Share (2016-2018)
Table Urologix Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Urologix Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Urologix Benign Prostatic Hyperplasia Devices Market Share (2016-2018)
Table Boston Scientific corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boston Scientific corporation Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Boston Scientific corporation Benign Prostatic Hyperplasia Devices Market Share (2016-2018)
Table Lisa Laser Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lisa Laser Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Lisa Laser Benign Prostatic Hyperplasia Devices Market Share (2016-2018)
Table Medifocus Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Medifocus Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Medifocus Benign Prostatic Hyperplasia Devices Market Share (2016-2018)
Table Neotrac Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Neotrac Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Neotrac Benign Prostatic Hyperplasia Devices Market Share (2016-2018)
Table ProArc Medical LTD Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ProArc Medical LTD Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2016-2018)
Figure ProArc Medical LTD Benign Prostatic Hyperplasia Devices Market Share (2016-2018)
Table Urotech GMBH Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Urotech GMBH Benign Prostatic Hyperplasia Devices Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Urotech GMBH Benign Prostatic Hyperplasia Devices Market Share (2016-2018)